
In a head-to-head RCT, Rezūm produced a 4.6-point greater IPSS improvement than combination pharmacotherapy at 1 year, according to Jean-Nicolas Cornu, MD, PhD, FEBU.
In this video, J. Curtis Nickel, MD, FRCSC, discusses the findings of the third part of the study, “Serenoa repens (saw palmetto) for lower urinary tract symptoms (LUTS): The evidence for efficacy and safety of lipidosterolic extracts,” which was conducted by Stephen B. Strum, MD, FACP. Nickel is a professor of urology at Queen’s University, and a research chair in urologic pain and inflammation at Kingston Health Sciences Centre, Kingston, Ontario, Canada.